Literature DB >> 10867215

Vascular and metabolic reserve in Alzheimer's disease.

K Nagata1, Y Kondoh, R Atchison, M Sato, Y Satoh, Y Watahiki, Y Hirata, E Yokoyama.   

Abstract

Vascular and metabolic reserve were analyzed in probable Alzheimer's disease (AD) and vascular dementia (VaD). Cerebral blood flow (CBF), cerebral blood volume (CBV), cerebral metabolic rate of oxygen (CMRO(2)), and oxygen extraction fraction (OEF) were measured quantitatively with positron emission tomography (PET). Vascular reactivity (VR) was also calculated by comparing the CBF during 5% CO(2) inhalation with the CBF during normal breathing. Vascular transit time (VTT) that was calculated as a ratio of CBV/CBF and VR reflect vasodilating capacity of the small resistance vessels, whereas OEF designates metabolic (oxygen-extraction) reserve in threatening brain ischemia. Significant increase in OEF was seen in the parieto-temporal cortex and both VTT and VR were preserved in AD patients. By constrast, there was no significant increase in OEF whereas VTT was prolonged and VR was markedly depressed in VaD patients. The increase of OEF and preserved VTT and VR seen in AD patients indicate the possible participation of vascular factors in the pathogenesis of AD perhaps at the capillary level.

Entities:  

Mesh:

Year:  2000        PMID: 10867215     DOI: 10.1016/s0197-4580(00)00130-5

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

1.  Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer's dementia.

Authors:  Stephan J Schreiber; Florian Doepp; Eike Spruth; Ute A Kopp; José M Valdueza
Journal:  J Neurol       Date:  2005-09-12       Impact factor: 4.849

2.  Three-dimensional mapping of brain venous oxygenation using R2* oximetry.

Authors:  Deng Mao; Yang Li; Peiying Liu; Shin-Lei Peng; Jay J Pillai; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2017-06-06       Impact factor: 4.668

3.  Cerebrovascular disease and patterns of cerebral oxygenation during sleep in elders.

Authors:  Barbara Waag Carlson; Virginia J Neelon; John R Carlson; Marilyn Hartman; Sunil Dogra
Journal:  Biol Res Nurs       Date:  2009-04       Impact factor: 2.522

Review 4.  Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease.

Authors:  Seth Love; J Scott Miners
Journal:  Brain Pathol       Date:  2016-09       Impact factor: 6.508

5.  Multimodal MRI neuroimaging biomarkers for cognitive normal adults, amnestic mild cognitive impairment, and Alzheimer's disease.

Authors:  Ai-Ling Lin; Angela R Laird; Peter T Fox; Jia-Hong Gao
Journal:  Neurol Res Int       Date:  2011-09-21

6.  Low Residual CBF Variability in Alzheimer's Disease after Correction for CO(2) Effect.

Authors:  Anders Bertil Rodell; Joel Aanerud; Hans Braendgaard; Albert Gjedde
Journal:  Front Neuroenergetics       Date:  2012-07-05

7.  Is the cerebellum the optimal reference region for intensity normalization of perfusion MR studies in early Alzheimer's disease?

Authors:  María Lacalle-Aurioles; Yasser Alemán-Gómez; Juan Adán Guzmán-De-Villoria; Isabel Cruz-Orduña; Javier Olazarán; José María Mateos-Pérez; María Elena Martino; Manuel Desco
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

Review 8.  Cerebrovascular disease in ageing and Alzheimer's disease.

Authors:  Seth Love; J Scott Miners
Journal:  Acta Neuropathol       Date:  2015-12-28       Impact factor: 17.088

9.  Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease.

Authors:  Ai-Ling Lin; Jordan B Jahrling; Wei Zhang; Nicholas DeRosa; Vikas Bakshi; Peter Romero; Veronica Galvan; Arlan Richardson
Journal:  J Cereb Blood Flow Metab       Date:  2015-12-31       Impact factor: 6.200

10.  Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer's disease.

Authors:  Ruiqing Ni; Markus Rudin; Jan Klohs
Journal:  Photoacoustics       Date:  2018-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.